The Predictive Value of Real-World Cardiologist Performance (RWCP) Score in Atrial Fibrillation Recurrence Risk After Radiofrequency Ablation

真实世界心脏病专家表现(RWCP)评分对射频消融术后房颤复发风险的预测价值

阅读:1

Abstract

OBJECTIVE: To explore the predictive value of Real-world Cardiologist Performance (RWCP) score for atrial fibrillation (AF) recurrence risk after radiofrequency catheter ablation (RFCA). METHODS: Patients with nonvalvular AF who underwent first-time RFCA at Luoyang Central Hospital affiliated to Zhengzhou University between October 2021 and June 2023 were included in this study. Detailed ablation data were exported from CARTO®3 system (Biosense Webster, USA), based on which, four parameters, including discharge time proportion, Catheter Contact Force Stability (C3-FOT proportion), Ablation Index Consistency (SURPOINT/TOP-4 proportion) and fragmented points proportion, were calculated. Then, the RWCP score was calculated from these parameters for each patient. Predictive value of the RWCP score for AF recurrence risk were assessed using Cox regression and Kaplan-Meier analyses. RESULTS: A total of 148 AF patients were enrolled, including 68 males and 80 females. During follow-up, 30 patients (20.3%) experienced AF recurrence. The RWCP score was calculated using Cox regression coefficients: RWCP score = (left ring discharge time ratio × 2.853) - (left C3-FOT proportion × 0.91) + (left SURPOINT/TOP4 × 2.943) + (left fragmented points proportion × 0.423) - (right ring discharge time ratio × 4.039) - (right C3-FOT proportion × 6.159) - (right SURPOINT/TOP4 × 1.312) - (right points fragmented proportion × 4.425). It was found that patients with higher RWCP scores (-12.53 to 5.79) had higher recurrence risk than those with low scores (-28.68 to -12.76) (HR = 5.55, 95% CI: 2.23-13.80, p = 0.0002). Kaplan-Meier analysis confirmed this (p(log-rank) < 0.001). To simplify the operation of RWCP, an online calculator was explored using shiny platform (https://doctorwanghao.shinyapps.io/RWCP_English/). CONCLUSION: The RWCP score shows promise as a tool for evaluating ablation completeness, assessing cardiologist performance and predicting AF recurrence risk after ablation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。